BackInnate Pharma Overview

Innate Pharma Other Assets

Track Innate Pharma's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Innate Pharma Other Assets History

Loading

Innate Pharma vs. peers: Other Assets Comparison

Loading

Innate Pharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Innate Pharma (IPHA) FAQ

As of the most recent data (December 2025), IPHA shows a other assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IPHA's other assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Innate Pharma is outperforming or lagging.

Tracking IPHA's other assets over time shows whether Innate Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Innate Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.

Innate Pharma's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.